Matthew Myntti
Founder en NEXT SCIENCE LIMITED .
Fortuna: 2 M $ al 31/03/2024
Perfil
Matthew Myntti is the founder of Next Science Ltd.
which was founded in 2017, where he holds the title of Chief Technology Officer.
He is currently a Director at Microbial Defense System Holdings, Inc. since 2012.
He previously worked at Synthes GmbH as the President-Asia Pacific.
Dr. Myntti received his undergraduate and doctorate degrees from the University of Dayton.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NEXT SCIENCE LTD
3.59% | 14/03/2023 | 10 472 969 ( 3.59% ) | 2 M $ | 31/03/2024 |
Cargos activos de Matthew Myntti
| Empresas | Cargo | Inicio |
|---|---|---|
| NEXT SCIENCE LIMITED | Founder | 20/10/2017 |
Microbial Defense System Holdings, Inc.
 Microbial Defense System Holdings, Inc. Financial ConglomeratesFinance Microbial Defense System Holdings, Inc. provides investment advice. The company is headquartered in Wilmington, DE. | Director/Board Member | 30/03/2012 |
Antiguos cargos conocidos de Matthew Myntti.
| Empresas | Cargo | Fin |
|---|---|---|
Synthes GmbH
 Synthes GmbH Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Synthes GmbH is a German company that manufactures and distributes healthcare equipment for traumatology, orthopaedy, oral and maxillofacial surgery, and neurosurgery. The private company is based in Umkirch, Germany. The company was founded in 2002. The CEO is Ulrich Jäggle. | Corporate Officer/Principal | - |
Formación de Matthew Myntti.
| University of Dayton | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NEXT SCIENCE LIMITED | Health Technology |
| Empresas privadas | 2 |
|---|---|
Synthes GmbH
Synthes GmbH Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Synthes GmbH is a German company that manufactures and distributes healthcare equipment for traumatology, orthopaedy, oral and maxillofacial surgery, and neurosurgery. The private company is based in Umkirch, Germany. The company was founded in 2002. The CEO is Ulrich Jäggle. | Health Technology |
Microbial Defense System Holdings, Inc.
Microbial Defense System Holdings, Inc. Financial ConglomeratesFinance Microbial Defense System Holdings, Inc. provides investment advice. The company is headquartered in Wilmington, DE. | Finance |
- Bolsa de valores
- Insiders
- Matthew Myntti
